Fusion single-stranded DNA polymerase Bst, nucleic acid molecule encoding the fusion DNA polymerase NeqSSB-Bst, method for preparing same and use thereof
The fusion of Bst polymerase with NeqSSB protein addresses limitations in DNA/RNA binding and inhibitor resistance, resulting in improved thermostability and processivity for isothermal amplification techniques.
Patent Information
- Application Number
- JP2020571711
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2018-06-27
- Filing Date
- 2019-06-26
- Publication Date
- 2024-11-08
- Estimated Expiration
- 2039-06-26
AI Technical Summary
Existing DNA polymerases, such as Bst, lack sufficient processivity, resistance to inhibitors, and affinity for DNA/RNA binding, which limits their effectiveness in isothermal amplification techniques.
A fusion DNA polymerase, NeqSSB-Bst, is created by linking Bst polymerase variants with the NeqSSB protein using a six amino acid linker or directly, enhancing its ability to bind all types of DNA and RNA, and improving thermostability and inhibitor resistance.
The fusion polymerase exhibits increased thermostability, processivity, and resistance to medical and environmental inhibitors, significantly enhancing its performance in isothermal amplification reactions.
Smart Images

Figure 0007579557000001 
Figure 0007579557000002 
Figure 0007579557000003
Abstract
Description
[Technical field]
[0001] The present invention relates to a fusion single-stranded DNA polymerase Bst and a preparation method thereof. The present invention also relates to a nucleic acid molecule encoding the fusion polymerase NeqSSB-Bst according to one of three variants of Bst polymerase: full length, large fragment, and short fragment, and the use of the fusion DNA polymerase in an isothermal amplification reaction.
[0002] DNA polymerases are enzymes that play a key role in the processes of DNA replication and repair. They are widely used in various fields of science and have been successfully employed in sequence analysis or in various PCR (polymerase chain reaction) variants, where they catalyze the in vitro DNA synthesis process, which is carried out in cycles with strictly defined thermal stages.
[0003] Another approach that is gaining popularity is the use of DNA polymerases in isothermal techniques for DNA amplification that are not based on thermal cycling, where the reaction is carried out at a constant elongation temperature. Many such techniques have been developed so far for both DNA and RNA amplification.
[0004] The choice of an appropriate polymerase for a given technique depends mainly on its properties. Besides the basic polymerization ability, polymerases can also exhibit the ability to hydrolyze DNA molecules due to the presence of an exonucleolytic domain or the presence of reverse transcriptase activity. These characteristics are determined by the presence of the respective domains. The basic domains present in these enzymes are the polymerization domain, as well as the 3'-5' and 5'-3' exonucleolytic domains.
[0005] There are polymerases in which deletion of the exonucleolytic domain leads to functional proteins with partially altered characteristics compared to the native enzyme. The most popular polymerase of this type is Taq polymerase isolated from the bacterium Thermus aquaticus, whose discovery has revolutionized molecular biology.
[0006] Without 5'-3' exonuclease activity, Taq 289 polymerase exhibits high thermostability, while more Mg 2+ ion, the newly formed DNA strand is less error-prone. Bst polymerase is used in isothermal amplification techniques. Its native form contains an inactive 3'-5' exonucleolytic domain and an active 5'-3' exonucleolytic domain, and has a cleavage site at position 73 (Tyr 73 ->Phe 73 and Tyr 73 ->Ala 73 Activity can be abolished by a point mutation at
[0007] This polymerase is a member of family A, like Taq polymerase, and is isolated from the bacterium Bacillus stearothermophilus. Its optimum activity is around 60°C, and without exonuclease activity, the polymerase shows strand displacement activity that is very useful in LAMP reactions. Although the polymerase has a high resistance to medical or environmental inhibitors compared to other polymerases of this family, considering the applications of this polymerase, it is still important to look for solutions that can mainly lead to improvements in processivity and resistance to inhibitors.
[0008] The NeqSSB protein is a member of the single-stranded DNA binding (SSB) protein family. SSB proteins have a variety of amino acid sequences and structures. However, they still contain one characteristic and highly conserved oligonucleotide / oligosaccharide binding (OB) fold domain of about 100 amino acids.
[0009] This domain is widely present in proteins that exhibit the ability to bind single-stranded DNA and therefore determines the fundamental commonality of all SSB proteins - the non-specific binding of single-stranded DNA and, much later, the RNA-binding ability. SSB proteins play an important role in processes closely related to single-stranded DNA. They are crucial in replication, genetic recombination and DNA repair. These proteins are responsible for interacting with single-stranded DNA, preventing the formation of secondary structures and protecting it from degradation by nucleases.
[0010] The discovery of SSB proteins occurred in the early 1960s. The first SSB proteins discovered were those of T4 phage and E. coli. During this discovery, their high interaction ability with single-stranded DNA and high protein elution ability using single-stranded DNA-cellulose beads at high salt concentrations (2M sodium chloride) were noted.
[0011] In addition, the protein was found to have a very high preference for single-stranded DNA, confirming the fundamental role of SSB proteins in processes related to single-stranded DNA, and the fact that these proteins are present in all living organisms as well as viruses.
[0012] The binding of SSB proteins to single-stranded DNA is based on the packing of aromatic amino acid residues between the residues of the oligonucleotide chain, and in addition, the positively charged amino acid residues interact with the phosphate backbone of the single-stranded DNA molecule.
[0013] The NeqSSB protein is called NeqSSB-like protein because it deviates from the characteristics of classical SSB proteins, despite the fact that it belongs to the SSB protein family. The protein is derived from the hyperthermophilic archaeon Nanoarchaeum equitans, a parasite of the craenarchaeon Ignicoccus hospitalis. The optimal growth conditions for this microorganism require strict anaerobic conditions at a temperature of 90°C.
[0014] Interestingly, Nanoarchaeum equitans contains the smallest known genome, consisting of 490,885 base pairs. In contrast to most known organisms with small genomes, this microorganism contains a full set of enzymes participating in replication, repair, and DNA recombination, and contains the SSB protein.
[0015] Like other proteins in this family, the NeqSSB protein has native DNA-binding activity. It consists of 243 amino acid residues, contains an OB domain in its structure, and is biologically active as a monomer, similar to the case of some viral SSB proteins.
[0016] Reports indicate that the NeqSSB protein, like other SSB proteins, exhibits extraordinary ability to bind all DNA types (single-stranded DNA, double-stranded DNA) and mRNA without conformational preference. In addition, the protein exhibits high thermostability; it has a half-life of 5 minutes at 100°C while maintaining biological activity, and a melting point of 100.2°C.
[0017] To meet the demands imposed by modern diagnostic techniques, molecular biology or genetic engineering, it is necessary to improve DNA polymerases with properties useful in these fields of science. Modifications introduced so far have focused mainly on the introduction of improved buffers, enhancers of the amplification reaction or mutations in the DNA polymerases. Mutations lead to obtaining enzymes with increased thermostability and resistance to inhibitors present in medical or environmental samples.
[0018] The mechanism of action of DNA polymerase involves several key steps. The first step consists of the contact of the enzyme with the DNA matrix. The resulting DNA-DNA complex associates with each dNTP (deoxyribonucleotide triphosphate) as a result of the nucleophilic attack of the 3'-hydroxyl (OH) group on the phosphorus atom of the nucleotide. The final step leads to the formation of a phosphodiester bond and the release of pyrophosphate.
[0019] One of the key stages of the polymerization activity of these enzymes, which contributes to their final efficiency, is the initial process associated with binding to the matrix DNA. For that reason, modifications of known polymerases are tailored to facilitate their binding to the DNA strand undergoing polymerization. An example of such a modification would be the generation of fusion DNA polymerases with proteins that show a natural ability to bind single-stranded and / or double-stranded DNA. The literature represents only a few examples of fusion DNA polymerases, most of which are fused to thermostable enzymes used primarily in the polymerase chain reaction method.
[0020] The studies suggest that fusion of Taq, Pfu, Tpa or KOD DNA polymerase with the DNA-binding protein Sso7d from the hyperthermophilic archaeon Sulfolobus solfataricus leads to a 5- to 17-fold increase in polymerase processivity. Similarly, increased fidelity and processivity of the DNA polymerase of the RB69 bacteriophage was observed after fusion with the native SSB protein (RB69SSB) that binds single-stranded DNA.
[0021] European patent EP1934372B1 discloses that a DNA polymerase from Thermococcus zilligi fused with the SsoSSB protein of the archaeon Sulfolobus solfataricus shows increased efficiency and processivity of the modified enzyme.
[0022] In addition, a fusion of the NeqSSB protein with the DBD domain of P. furiosus ligase, capable of binding to all kinds of DNA, and TaqStoffel polymerase was recently reported. Both fusions led to improved functional properties of the enzyme, in particular the processivity and thermostability of the native enzyme, and significantly increased its resistance to clinical inhibitors (lactoferrin, heparin, whole blood).
[0023] A few fusion polymerases, such as Bst and 0029, used in isothermal reactions, were also introduced. These were linked via the HhH (helix-heparin-helix) domain of topoisomerase V from Methanopyrus kandleri, increasing the affinity of the polymerase for DNA without negatively affecting its strand displacement activity (described in the fusion polymerases Bst and 0029). In addition, higher fidelity and amplification efficiency were observed using plasmid and genomic DNA (in the case of reference 029).
[0024] The publication also presents a fusion of a Bst-like polymerase isolated from Geobacillu sp. 777. Chimeras of the polymerase with the DBD domain of the ligase Pyrococcus abyssi and the Sto7d protein have been generated and showed increased processivity and resistance to inhibitors (urea, whole blood, heparin, EDTA, sodium chloride and ethanol) compared to the native polymerase. [Prior art documents] [Patent documents]
[0025] [Patent Document 1] European Patent EP1934372B1 [Non-patent literature]
[0026] [Non-Patent Document 1] Patel PH, Motoshi S., Adman E., Shinkai A, Prokaryotic DNA Polymerase I: Evolution, Structure and Base Flipping Mechanism for Nucleotide Selection, J Mol Biol., 2001, 308: 823-837. [Non-Patent Document 2] Steitz TA, The Journal of Biological Chemistry, 1999, 274: 17395 -17398 [Non-Patent Document 3] Riggs MG, Tudor S., Sivaram M., McDonough SH Construction of single amino acid substitution mutants of cloned Bacillus stearothermophilusDNA polymerase I which lack 5'- 3' exonuclease activity. Biochim Biophys Acta, 1996; 1307(2): 178-86. [Non-Patent Document 4] Oscorbin IP, Belousova EA, Boyarskikh UA, Zakabunin AI, Khrapov EA, Filipenko ML, Derivatives of Bst-like Gss-polymerase with improved processivity and inhibitor tolerance, Nucleic Acids Research, 2017, 45 (16): 9595-9610
Direct Environment 5
Outdoor Configuration6
Direct Environment 7
Outdoor Track 8
Outdoor Tools9
Outdoor Tools 10
Outdoor Content11
Non-Patent Document 12
Non-Patent Document 13
Non-Patent Document 14
Non-Patent Document 15
Outdoor Content 16
Outdoor Track 17
Outdoor Tools 18
Outdoor Tools 19
[0027] The object of the present invention is to provide a DNA polymerase Bst fused with the NeqSSB protein that binds to all kinds of DNA and RNA. Surprisingly, this problem has been solved to a high extent in the present invention. [Means for solving the problem]
[0028] The present invention relates to a DNA polymerase Bst fused with NeqSSB protein that binds to any kind of DNA and RNA. Three Bst polymerase variants have been modified: Full length - the entire amino acid sequence of DNA I Bst polymerase with 5'-3' activity arrested due to a point mutation; Long fragment - DNA I Bst polymerase without the 5'-3' domain; Short fragment - a short version lacking both exonucleolytic domains. All variants of Bst polymerase are fused to NeqSSB protein at the N-terminus of the polymerase using a linker of 6 amino acids.
[0029] The essence of the present invention is a fusion polymerase of single-stranded DNA polymerase Bst or another polymerase of this class of DNA polymerase, which binds to NeqSSB protein or a protein having a sequence similar to NeqSSB at a rate of 50% or less, and which is linked at the N-terminus of the polymerase using a linker of the representative amino acid sequence Gly-Ser-Gly-Gly-Val-Asp or is directly fused without a linker, and which exists as three different variants.
[0030] The fusion DNA polymerase NeqSSB-Bst is a variant of three Bst polymerases: Full-length - the complete amino acid sequence of DNA polymerase I Bst with 5'-3' activity stalled due to a point mutation; Long fragment-DNA polymerase I without 5'-3' domain Bst; Short fragment - a short version with both exonucleolytic domains deleted; Contains one of the following:
[0031] The fusion DNA polymerase NeqSSB-Bst binds to all kinds of DNA and RNA. The fusion DNA polymerase NeqSSB-Bst has the sequence represented by SEQ.1. The fusion DNA polymerase NeqSSB-Bst has the sequence represented by SEQ.2. The fusion DNA polymerase NeqSSB-Bst having the sequence represented by SEQ.3. A nucleic acid molecule encoding the full-length fusion DNA polymerase NeqSSB-Bst represented by SEQ.4. A nucleic acid molecule encoding a long fragment of the fusion DNA polymerase NeqSSB-Bst represented by SEQ.5. A nucleic acid molecule encoding a short fragment of the fusion DNA polymerase NeqSSB-Bst represented by SEQ.6.
[0032] A nucleic acid molecule encoding the fusion DNA polymerase NeqSSB-Bst.
[0033] The method for preparing the above-mentioned fusion DNA polymerase NeqSSB-Bst comprises the steps of: expressing the gene encoding the enzyme under optimized conditions in a microorganism shaker, in which the growth temperature is 28-37° C., the incubation time of the medium after induction is 3-20 hours, and the inductor concentration is 0.1-1 mM isopropyl-β-D-thiogalactoside; The resulting cell lysate is subjected to digestion using sonication and removal of DNA genetic contamination using double-stranded DNase.
[0034] The second purification step utilizes metal affinity chromatography using histidine capture beads; The next steps cover three dialysis (10 mM Tris-HCl pH 7.1, 50 mM potassium chloride, 1 mM DTT, 0.1 mM EDTA, 50% glycerol, 0.1% Triton X-100), gel filtration and concentration of the preparation.
[0035] All processes are carried out at 4°C. The purity of the obtained protein was tested using SDS-PAGE electrophoresis, and the number of units of the obtained preparation was determined using the EvaEZ fluorometric polymerase activity assay kit.
[0036] In vitro use of the above fused single-stranded DNA polymerase Bst for isothermal amplification reaction. [Brief description of the drawings]
[0037] [Description of sequence and drawing] Seq. 1 shows the full-length amino acid sequence of the fusion polymerase NeqSSB-Bst. Seq.2 represents the amino acid sequence of the fusion polymerase NeqSSB-Bst long fragment. Seq.3 shows the amino acid sequence of the short fragment of the fusion polymerase NeqSSB-Bst. Seq. 4 shows the sequence of the gene encoding the full-length fusion DNA polymerase NeqSSB-Bst. Seq. 5 shows the sequence of the gene encoding the fusion DNA polymerase NeqSSB-Bst long fragment. Seq. 6 shows the sequence of the gene encoding the fusion DNA polymerase NeqSSB-Bst short fragment.
[0038] [Figure 1] Figure 1 represents the electrophoretic 10% polyacrylamide gel separation of proteins from the individual stages of purification of the fusion DNA polymerase. M - protein mass markers with masses of standard proteins (Thermo-Fisher Scientific): 116; 66,2; 45; 35; 25; 18.4; 14.4 kDa; 1 - total cell-free extract of recombinant E. coli TOP10F'-pETNeqSSB-Bst strain; 2 - total cell-free extract subjected to preliminary heat denaturation; 3 - fraction not binding to the histidine capture column; 4 - washing fraction of histidine capture beads with 40 mM imidazole; 5 - washing fraction of histidine capture beads with 100 mM imidazole; 6 - recovered fraction containing the fusion DNA polymerase after elution with 500 mM imidazole. [Diagram 2] Figure 2 shows a chart of EvaGreen dye fluorescence over time starting DNA amplification for a fusion DNA polymerase, allowing the calculation of the number of DNA polymerase units. An example is shown of the amount (in microliters) of DNA polymerase used in the reaction against the curve. [Diagram 3]Figure 3 shows 10% polyacrylamide gel separation by electrophoresis of lysates for various expression conditions. M - protein mass markers (Thermo-Fisher Scientific) with masses of standard proteins: 116; 66,2; 45; 35; 25; 18.4; 14.4 kDa; 1 - total cell-free extract of recombinant E. coli TOP10F'-pETNeqSSB-Bst strain before induction; 2 - total cell-free extract 3 hours after induction with 1 mM isopropyl-β-D-thiogalactoside, expression was induced at 28°C; 3 - total cell-free extract 4 hours after induction with 1 mM isopropyl-β-D-thiogalactoside, expression was induced at 28°C; 4 - total cell-free extract 5 hours after induction with 1 mM isopropyl-β-D-thiogalactoside, expression was induced at 28°C. 5 - whole cell-free extract 6 hours after induction with 1 mM isopropyl-β-D-thiogalactoside, expression was induced at 28°C. 6 - whole cell-free extract 20 hours after induction with 1 mM isopropyl-β-D-thiogalactoside, expression was induced at 28°C. 7 - whole cell-free extract 3 hours after induction with 0.1 mM isopropyl-β-D-thiogalactoside, expression was induced at 28°C. 8 - whole cell-free extract 4 hours after induction with 0.1 mM isopropyl-β-D-thiogalactoside, expression was induced at 28°C. 9 - whole cell-free extract 5 hours after induction with 0.1 mM isopropyl-β-D-thiogalactoside, expression was induced at 28°C. 10 - total cell-free extract 6 hours after induction with 0.1 mM isopropyl-β-D-thiogalactoside, expression was induced at 28°C. 11 - total cell-free extract 20 hours after induction with 0.1 mM isopropyl-β-D-thiogalactoside, expression was induced at 28°C. 12 - total cell-free extract of recombinant E. coli strain TOP10F'-pETNeqSSB-Bst before induction; 13 - total cell-free extract 3 hours after induction with 1 mM isopropyl-β-D-thiogalactoside, expression was induced at 37°C. 14 - total cell-free extract 4 hours after induction with 1 mM isopropyl-β-D-thiogalactoside, expression was induced at 37°C.15 - whole cell-free extract 5 hours after induction with 1 mM isopropyl-β-D-thiogalactoside, expression was induced at 37°C. 16 - whole cell-free extract 6 hours after induction with 1 mM isopropyl-β-D-thiogalactoside, expression was induced at 37°C. 17 - whole cell-free extract 20 hours after induction with 1 mM isopropyl-β-D-thiogalactoside, expression was induced at 37°C. 18 - whole cell-free extract of recombinant E. coli strain TOP10F'-pETNeqSSB-Bst before induction; 19 - whole cell-free extract 3 hours after induction with 0.1 mM isopropyl-β-D-thiogalactoside, expression was induced at 37°C. 20 - whole cell-free extract 4 hours after induction with 0.1 mM isopropyl-β-D-thiogalactoside, expression was induced at 37°C. 21 - Whole cell-free extract 5 hours after induction with 0.1 mM isopropyl-β-D-thiogalactoside, expression was induced at 37° C. 22 - Whole cell-free extract 6 hours after induction with 0.1 mM isopropyl-β-D-thiogalactoside, expression was induced at 37° C. 23 - Whole cell-free extract 20 hours after induction with 0.1 mM isopropyl-β-D-thiogalactoside, expression was induced at 37° C. [Figure 4] Figure 4 is a graph showing the change in fusion DNA polymerase activity with increasing temperature compared to the control DNA polymerase I Bst. The blue line represents the results of DNA polymerase I Bst, the red line represents the full length fusion DNA polymerase Bst, the purple line represents the long fragment fusion DNA polymerase Bst, and the green line represents the short fragment fusion DNA polymerase Bst. The activity is evaluated using the GelAnalyzer program based on the intensity of the PCR product obtained in agarose gel. [Diagram 5] Figure 5 shows electrophoretic separations in a 1.5% agarose gel with ethidium bromide showing a comparison of DNA polymerase processivities, defined as the amplification rate during isothermal PCR. Reactions were run for various cycles, as indicated by the underlined results. [Figure 6]FIG. 6 shows electrophoretic separations in a 1.5% agarose gel illustrating the comparison of DNA polymerase resistance to inhibitors: blood lactoferrin (A) and soil polyphenols (B). A: 1-6 μg lactoferrin added reaction products resulting from DNA amplification2-0.6 μg lactoferrin added reaction products resulting from DNA amplification3-0.06 μg lactoferrin added reaction products resulting from DNA amplification4-6 ng lactoferrin added reaction products resulting from DNA amplification without the addition of K + -inhibitorsB: 1-100 μg polyphenol added reaction products resulting from DNA amplification2-10 μg polyphenol added reaction products resulting from DNA amplification3-1 μg polyphenol added reaction products resulting from DNA amplification4-0.1 μg polyphenol added reaction products resulting from DNA amplification without the addition of K + -inhibitors [Figure 7] Figure 7 shows electrophoretic separation on a 2% agarose gel with ethidium bromide showing the results of a DNA electrophoretic mobility shift assay in the presence of the fusion DNA polymerase. The reaction mixture contained 10 pmol (dT76) fluorescein-labeled product (green) and 2.5 pmol of the 100 base pair PCR product (orange). 1-d(T)762-100 bp3-d(T)76+100 bp+3.3 pmol of fusion DNA polymerase4-d(T)76+100 bp+6.6 pmol of fusion DNA polymerase5-d(T)76+100 bp+13.2 pmol of fusion DNA polymerase6-d(T)76+100 bp+26.4 pmol of fusion DNA polymerase7-d(T)76+100 bp+52.8 pmol of fusion DNA polymerase8-d(T)76+100 bp+105.6 pmol of fusion DNA polymerase9-d(T)76+100 bp+211.2 pmol of fusion DNA polymerase DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0039] The present invention will be described with reference to the embodiments. The present invention includes the embodiments, but the present invention is not limited to the embodiments. EXAMPLES
[0040] <Fused DNA polymerase NeqSSB-Bst> The fusion DNA polymerase NeqSSB-Bst was obtained by fusing the NeqSSB protein with three different Bst polymerases at the N-terminus of the polymerase using a linker consisting of six amino acids with the following sequence: Gly-Ser-Gly-Gly-Val-Asp. The sequences of the three variants of the fusion DNA polymerase are presented in the figures, SEQ.1-3 (amino acid sequence) and SEQ.4-6 (nucleotide sequence). The DNA polymerase was obtained on a laboratory scale in an E. coli-based prokaryotic system.
[0041] Preparation - Example 1 The first step in the preparation of DNA polymerase involves expressing the gene encoding the enzyme under optimized conditions in a microbial shaker with a growth temperature of 30°C, incubation time of the post-induction medium of 3-20 h, and an inductor concentration of 0.1-1 mM isopropyl-β-D-thioglycoside.
[0042] In the protein purification process, the resulting cell lysate is subjected to digestion using sonication and removal of DNA genetic contamination using dsDNA enzyme. Due to the presence of oligohistidine domains, the second purification step utilizes metal affinity chromatography using histidine capture beads (Figure 1).
[0043] The next steps cover three dialysis steps (10 mM Tris-HCl pH 7.1, 50 mM KCl, 1 mM DTT, 0.1 mM EDTA, 50% glycerol, 0.1% Triton X-100) until conditions with stability for DNA polymerase are obtained, gel filtration and densification of the preparation. All processes were carried out at 4°C.
[0044] The purity of the obtained protein was tested using SDS-PAGE electrophoresis, and the number of units of the obtained preparation was determined using the EvaEZ fluorometric polymerase activity assay kit from Biotium (USA) according to the unit definition (1 activity unit [1U] is the amount of DNA polymerase that can incorporate 10 nmol of nucleotides in 30 min at the optimal operating temperature of 65°C (Figure 2)). One liter of laboratory-scale medium provides about 5 mg of purified preparation with an activity of about 10,000 U, allowing each number of amplification reactions.
[0045] Preparation Example 2 Expression of the gene encoding the fusion DNA polymerase was carried out under conditions with adequate oxygenation of the liquid medium at a temperature of 28°C. Exponentially growing cultures were induced with isopropyl-β-D-thiogalactoside ranging from 1 mM to 0.1 mM, an amount that provided protein expression in 3 to 20 hours of incubation (Figure 3).
[0046] The cell lysate was then mechanically digested and purified using metal affinity chromatography and ion exchange chromatography. The resulting fusion DNA polymerase was dialyzed for storage in 10 mM Tris-HCl pH 7.1, 50 mM KCl, 1 mM DTT, 0.1 mM EDTA, 50% glycerol, 0.1% Triton X-100, and provided at a concentration of 1 U / μL according to the unit definition of the commercially available Biotium (USA) EvaEZ fluorometric polymerase activity assay kit.
[0047] Preparation Example 3 Efficient expression of the gene encoding polymerase Bst fused to the NeqSSB protein was obtained by induction with isopropyl-β-D-thiogalactoside ranging from 1 mM to 0.1 mM for 3 to 20 h in medium at 37°C (Fig. 3).
[0048] The centrifuged and mechanically disrupted cell lysates were purified using chromatographic techniques (metal affinity and ion exchange chromatography) and suspended in formulation buffer (10 mM Tris-HCl pH 7.1, 50 mM KCl, 1 mM DTT, 0.1 mM EDTA, 50% glycerol, 0.1% Triton X-100) at a concentration of 1 U / μL. The amount of DNA units was determined based on the unit definition using the EvaEZ fluorometric polymerase activity assay kit from Biotium (USA).
[0049] Analysis of the enzymatic properties of the subject invention in comparison with the control DNA polymerase Bst shows that the presence of the added DNA-binding NeqSSB protein has a positive effect on the DNA polymerase properties: the thermostability of all the obtained DNA polymerase fusion variants was increased by about 20% compared to the control DNA polymerase Bst (Figure 4).
[0050] In addition, the DNA polymerase fused to the NeqSSB protein showed three times the processivity (Figure 5). The fusion DNA polymerase was tolerant to the concentrations of medical inhibitors (lactoferrin, heparin) and environmental inhibitors (humic acid, soil, polyphenols) in the reaction mixture, which increased the tolerance by several fold compared to the control polymerase (Figure 6). The fusion DNA polymerase showed a several fold increase in sensitivity compared to the control DNA polymerase Bst, indicating an increased affinity for the DNA matrix.
Claims
1. A fusion DNA polymerase NeqSSB-Bst in which the NeqSSB protein and the single-stranded DNA polymerase Bst are linked via a linker having an amino acid sequence of Gly-Ser-Gly-Gly-Val-Asp, the NeqSSB protein is bound to the N-terminus of the single-stranded DNA polymerase Bst via the linker; The polymerase exists as one of three different variants: The three different variants are: Full length - the complete amino acid sequence of DNA polymerase Bst with 5'-3' activity terminated due to a point mutation; Long fragment - DNA polymerase Bst without 5'-3' domain; or Short fragment - a short version with both exonucleolytic domains deleted; and The fusion DNA polymerase NeqSSB-Bst, capable of binding to all types of DNA and RNA.
2. The fusion DNA polymerase NeqSSB-Bst according to claim 1, which comprises a sequence represented by SEQ1, SEQ2 or SEQ3.
3. A nucleic acid molecule encoding a full-length fusion DNA polymerase NeqSSB-Bst represented by SEQ4, wherein the full-length fusion DNA polymerase NeqSSB-Bst has a sequence represented by SEQ1.
4. A nucleic acid molecule encoding a fusion DNA polymerase NeqSSB-Bst long fragment represented by SEQ5, wherein the fusion DNA polymerase NeqSSB-Bst long fragment has a sequence represented by SEQ2.
5. A nucleic acid molecule encoding a fusion DNA polymerase NeqSSB-Bst short fragment represented by SEQ6, said fusion DNA polymerase NeqSSB-Bst short fragment having a sequence represented by SEQ3.
6. A method for preparing the fusion DNA polymerase NeqSSB-Bst according to claim 1, comprising: The first step comprises expressing the gene encoding the enzyme under optimized conditions in a microorganism shaker, with a growth temperature of 28-37° C., an incubation time of the post-induction medium of 3-20 hours, and an inductor concentration of isopropyl-β-D-thiogalactoside of 0.1-1 mM; The resulting cell lysate is subjected to digestion using ultrasound and removal of DNA genetic contamination using double-stranded DNA degrading enzyme, The second purification step utilizes metal affinity chromatography using histidine capture beads; The next steps covered three dialysis (10 mM Tris-HCl pH 7.1, 50 mM KCl, 1 mM DTT, 0.1 mM EDTA, 50% glycerol, 0.1% Triton X-100), gel filtration, and concentration of the preparation. All processes were carried out at 4°C. A method for preparing the fusion DNA polymerase NeqSSB-Bst, characterized in that the purity of the obtained protein is tested using SDS-PAGE electrophoresis, and the number of units of the obtained preparation is prepared using the EvaEZ Fluorometric Polymerase Activity Assay Kit.
7. 3. In vitro use of the fusion DNA polymerase NeqSSB-Bst as defined in claim 1 or 2 in an isothermal amplification reaction.
Citation Information
Patent Citations
SSB - polymerase fusion proteins
EP1934372B1
ssb-polymerase fusion protein
JP2009520461A
Compositions and methods relating to variant DNA polymerases and synthetic DNA polymerases
WO2013033528A1
